Insmed(美國)

Insmed

Insmedwww.insmed.comInsmed是一家生物制藥上市公司。Insmed擁有為肺提供獨(dú)特的liposomal吸入式給藥專利技術(shù)。InsmedIncorporatedisabiopharmaceuticalcompanydedicatedtoimprovingthelivesofpatientsbattlingseriouslungdiseasesthroughthedevelopm entandcommercializationofinhalationtherapiesinorphanpatientpopulationswithcriticalunmetneeds.Insmed'sleadcandidate,ARIKACE®orliposomalamikacinforinhalation,isengineeredtodeliveraprovenandpotentanti-infectivedirectlytothesiteofseriouslunginfectionstoimprovetheefficacy,safetyandconvenienceoftreatmentforatleasttwoidentifiedpatientpopulations:cysticfibrosis(CF)patientswithPseudomonasaeruginosalunginfectionsandpatientswithnon-tuberculousmycobacterialunginfections(NTM).Insmed'sphase3registrationalstudyofARIKACEinEuropeandCanadacompletedenrollmentandtheCompanyexpectstop-lineclinicalresultsinmid-2013.Insmed'sphase2clinicaltrialinpatientswithNTM